Usana Health Sciences Inc (FRA:USJ)
€ 37.6 0.2 (0.54%) Market Cap: 734.51 Mil Enterprise Value: 429.29 Mil PE Ratio: 14.59 PB Ratio: 1.48 GF Score: 69/100

Q3 2024 USANA Health Sciences Inc Earnings Call Transcript

Oct 23, 2024 / 03:00PM GMT
Release Date Price: €33.2 (+5.73%)

Key Points

Positve
  • Usana Health Sciences Inc (USNA) increased active customer counts by 7% year-over-year in the China market, indicating growth in customer base.
  • The company successfully hosted a convention in Las Vegas, receiving positive feedback from associates, which could enhance sales leader engagement and business growth.
  • Usana Health Sciences Inc (USNA) launched new products, Celavive Resurfacing Serum and Whey Protein Isolate, in the US and Canada, showcasing their product innovation strategy.
  • The company has a robust pipeline of new products planned for 2025, indicating a focus on future growth and market expansion.
  • Usana Health Sciences Inc (USNA) has restructured its product development process, leading to faster product launches and increased agility in bringing products to market.
Negative
  • Third quarter net sales fell short of internal expectations due to challenging operating environments in key markets, particularly in China.
  • Despite an increase in active customers, net sales in China declined by 4% due to a decrease in average spend per customer.
  • The company anticipates a continued challenging operating environment through the remainder of the year, which may impact future sales.
  • Reduced advertising expenses contributed to lower SG&A, but there is concern about whether this reduction impacted third-quarter sales.
  • The revised guidance for the year implies a significant reduction in fourth-quarter EPS estimates, primarily due to increased promotional spending and margin pressures.
Operator

Good day, and welcome to today's USANA Health Sciences third quarter earnings conference call. While today's recorded presentation, all participants will be in a listen-only mode. (Operator Instructions) And now I'd like to hand the call over to Andrew Masuda. Please go ahead, sir.

Andrew Masuda
USANA Health Sciences Inc - Investor Relation

Thank you, Sergei, and good morning, everyone. We appreciate you joining us to review our third quarter 2024 results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.usana.com. Shortly following the call, a replay will be available on our website.

As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ perhaps materially from the results projected in such forward-looking statements.

Examples of these statements include those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot